Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cell cycle regulation proteins are a diverse group of molecules that orchestrate the orderly progression of eukaryotic cells through the phases of the cell division cycle. The most prominent members include cyclins and their partners, the cyclin-dependent kinases (CDKs), as well as various CDK inhibitors and checkpoint regulators. These proteins ensure that DNA is accurately replicated and segregated into daughter cells by controlling transitions between different phases such as G1, S, G2, and M. Dysregulation or mutation of these proteins is a hallmark feature in many cancers and other diseases characterized by abnormal proliferation. As such, several have become validated therapeutic targets; for example, selective inhibition of CDKs has led to approved drugs for certain cancers. However, "cell cycle regulation proteins" refers to an entire class rather than a single molecular entity; thus it is not specific enough for precise drug targeting or biomarker development without further specification.[1][3][5] Note: The term "Cell cycle regulation proteins" is overly broad—it encompasses multiple distinct molecular targets including but not limited to various cyclins (e.g., Cyclin D), CDKs (e.g., CDK4/6), tumor suppressors like retinoblastoma protein (pRb), transcription factors like E2F family members, and checkpoint kinases such as WEE1.[7] For structured data extraction or drug discovery purposes it is necessary to specify which individual member(s) are being referenced.
– Inhibition of cyclin-dependent kinases to arrest cell cycle progression at G1/S or G2/M checkpoints[1][5] – Induction of apoptosis in rapidly dividing cells by blocking key regulators[1][5]
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell cycle regulation protein (null).